AFAkira Fukao

Akira Fukao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Akira Fukao has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The association between coffee consumption and bladder cancer incidence in a pooled analysis of the Miyagi Cohort Study and Ohsaki Cohort Study

    by Kemmyo Sugiyama, Yumi Sugawara, Yasutake Tomata, Yoshikazu Nishino, Akira Fukao, Ichiro Tsuji

    Recent epidemiological studies of the association between coffee consumption and the risk of bladder cancer have yielded conflicting results. The aim of the present study was to examine the association between coffee consumption and the incidence of bladder cancer on the basis of pooled data from two cohort studies carried out in Miyagi Prefecture, northeastern Japan. We delivered self-administered questionnaires inquiring about the frequency of coffee consumption and other lifestyle factors in 1990 for the Miyagi Cohort Study and in 1994 for the Ohsaki Cohort Study. We followed 73 346 individuals from both cohorts and identified 274 cases of bladder cancer during 17.6 years for the Miyagi Cohort Study and 13.3 years for the Ohsaki Cohort Study. The multivariate-adjusted hazard ratios (95% confidence intervals) of bladder cancer incidence for the individuals who drank coffee occasionally, 1–2 cups/day, and 3 or more cups/day compared with never drinkers were 1.22 (0.90–1.66), 0.88 (0.61–1.26), and 0.56 (0.32–0.99), respectively (P trend=0.04). The inverse association remained even after stratification for smoking status. These data indicate that there is a significant inverse association between coffee consumption and the risk of bladder cancer.


  • Open Access

    Medical Institutions and Twitter: A Novel Tool for Public Communication in Japan

    by Yuya Sugawara, Hiroto Narimatsu, Atsushi Tsuya, Atsushi Tanaka, Akira Fukao

    A multidisciplinary journal that focuses on public health and technology, public health informatics, mass media campaigns, surveillance, and innovation in public health practice and research. Also dedicated to rapid open data sharing during epidemics.


  • Open Access

    Erratum to: Associations between DSM-IV mental disorders and diabetes mellitus: a role for impulse control disorders and depression

    by Peter de Jonge, Jordi Alonso, Dan J. Stein, Andrzej Kiejna, Sergio Aguilar-Gaxiola, Maria Carmen Viana, Zhaorui Liu, Siobhan O’nEill, Ronny Bruffaerts, Jose Miguel Caldas-De-Almeida, et al.

  • Open Access

    Cost-Effectiveness Analysis of Mass Screening for Cervical Cancer in Japan

    by Gen Matsunaga, Ichiro Tsuji, Shinji Sato, Akira Fukao, Shigeru Hisamichi, Akira Yajima

    Cost-effectiveness analysis for cervical cancer screening in Japan was performed to estimate the cost per life-year saved by the screening; cost-effectiveness ratio (CER). The analysis was made using a simulation model to estimate long-term cost and effectiveness of the screening programs. CER of cervical cancer screening was estimated to be US 40, 604 which was 2.4 times more expensive than that for gastric cancer screening but was about the same as that for colorectal cancer screening. It was within the range of cost-effectiveness of other cancer screening programs financed under the Health and Medical Services Law for the Aged in Japan. We performed sensitivity analysis on the following seven estimates, the screening charge, the sensitivity and the specificity of the screening test, the frequency of carcinoma in situ (CIS) among cases detected in the screening program, the initial cost and the terminal cost for patients with invasive cancer, and the incidence rate of cervical cancer. The sensitivity analysis demonstrated that the screening charge was the most influential factor on CER. CER was fairly stable under various assumptions on the accuracy of the screening test, the frequency of carcinoma in situ (CIS), the treatment cost for patient, and the incidence of cervical cancer. CER was less sensitive to the changes in incidence, even to as low as a 50% decrease of the current figure. Then if the incidence rate becomes 85% of the current figure in 2015, CER would be US 48, 176 and it was suggested that the cervical cancer screening would remain reasonably costeffective until the year 2015. J Epidemiol, 1997 ; 7 : 135-141.